Genericart Medicine Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.75 Cr
- Revenue Growth 2.29%
- Profit Growth -74.48%
- Ebitda 41.55%
- Net Worth 7.36%
- Total Assets 26.28%
About Genericart Medicine
Genericart Medicine Private Limited (GMPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 02 February 2016 (Eight years and 11 months 29 days old ). Its registered office is in Sangli, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹5.75 Cr.
Taherin Sayyed, Salim Sayyad, Shripad Kolhatkar, and One other member serve as directors at the Company.
Company Details
- Location
Sangli, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
- Apps
Corporate Identity Details
- CIN/LLPIN
U24290PN2016PTC158184
- Company No.
158184
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Feb 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Genericart Medicine?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shripad Kolhatkar  | Director | 02-Feb-2016 | Current |
| Taherin Sayyed | Director | 01-Jul-2020 | Current |
| Salim Sayyad | Director | 02-Feb-2016 | Current |
| Smita Kolhatkar | Director | 01-Jul-2020 | Current |
Financial Performance of Genericart Medicine.
Genericart Medicine Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 2.29% increase. The company also saw a substantial fall in profitability, with a 74.48% decrease in profit. The company's net worth moved up by a moderate rise of 7.36%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Genericart Medicine?
In 2023, Genericart Medicine had a promoter holding of 99.00% and a public holding of 1.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Factum Life Science LlpSalim Sayyad, Shripad Kolhatkar and 1 more are mutual person
Charges (Loans)
₹5.75 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 5.75 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Feb 2022 | Others | ₹5.75 Cr | Open |
How Many Employees Work at Genericart Medicine?
Genericart Medicine has a workforce of 102 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Genericart Medicine, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genericart Medicine's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.